Cancer Therapeutics Market To Reach USD 176 Billion By 2026
The report analyzes and forecasts the Cancer Therapeutics Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Cancer Therapeutics Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Cancer Therapeutics Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Cancer Therapeutics Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/1626
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
The players profiled in the report are AbbVie Inc., Astellas Pharma Inc., Bristol Myers Squibb Company, Celgene Corporation, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc. and others. The major players are involved in mergers & acquisition and partnership for expanding the market share.
The major market segments of Cancer Therapeutics Market are as below:
Market By Application
- Blood Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Breast Cancer
- Cervical Cancer
- Head and Neck Cancer
- Glioblastoma
- Malignant Meningioma
- Mesothelioma
- Melanoma
- Others
Market By Treatment Type
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Hormonal Therapy
- Others
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Cancer Therapeutics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Cancer Therapeutics Market By Application
1.2.2.1. Global Cancer Therapeutics Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.2.2. Global Cancer Therapeutics Market Revenue Share By Application in 2018
1.2.2.3. Blood Cancer
1.2.2.4. Colorectal Cancer
1.2.2.5. Prostate Cancer
1.2.2.6. Breast Cancer
1.2.2.7. Cervical Cancer
1.2.2.8. Head and Neck Cancer
1.2.2.9. Glioblastoma
1.2.2.10. Malignant Meningioma
1.2.2.11. Mesothelioma
1.2.2.12. Melanoma
1.2.2.13. Others
1.2.3. Cancer Therapeutics Market By Treatment Type
1.2.3.1. Global Cancer Therapeutics Market Revenue and Growth Rate Comparison By Treatment Type (2015-2026)
1.2.3.2. Global Cancer Therapeutics Market Revenue Share By Treatment Type in 2018
1.2.3.3. Chemotherapy
1.2.3.4. Targeted Therapy
1.2.3.5. Immunotherapy
1.2.3.6. Hormonal Therapy
1.2.3.7. Others
1.2.4. Cancer Therapeutics Market By Geography
1.2.4.1. Global Cancer Therapeutics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Cancer Therapeutics Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Cancer Therapeutics Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Cancer Therapeutics Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Cancer Therapeutics Major Manufacturers in 2018
CHAPTER 4. CANCER THERAPEUTICS MARKET BY APPLICATION
4.1. Global Cancer Therapeutics Revenue By Application
4.2. Blood Cancer
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Lung Cancer
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Colorectal Cancer
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Prostate Cancer
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.6. Breast Cancer
4.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.7. Cervical Cancer
4.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.8. Head and Neck Cancer
4.8.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.9. Glioblastoma
4.9.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.9.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.10. Malignant Meningioma
4.10.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.10.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.11. Mesothelioma
4.11.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.11.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.12. Melanoma
4.12.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.12.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.13. Others
4.13.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.13.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 5. CANCER THERAPEUTICS MARKET BY TREATMENT TYPE
5.1. Global Cancer Therapeutics Revenue By Treatment Type
5.2. Chemotherapy
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Targeted Therapy
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Immunotherapy
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.5. Hormonal Therapy
5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.6. Others
5.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 6. NORTH AMERICA CANCER THERAPEUTICS MARKET BY COUNTRY
6.1. North America Cancer Therapeutics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2. North America Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Cancer Therapeutics Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
CHAPTER 7. EUROPE CANCER THERAPEUTICS MARKET BY COUNTRY
7.1. Europe Cancer Therapeutics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. Europe Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.6.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.7.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
CHAPTER 8. ASIA-PACIFIC CANCER THERAPEUTICS MARKET BY COUNTRY
8.1. Asia-Pacific Cancer Therapeutics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Asia-Pacific Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.8.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
CHAPTER 9. LATIN AMERICA CANCER THERAPEUTICS MARKET BY COUNTRY
9.1. Latin America Cancer Therapeutics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Latin America Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
9.4. Mexico
9.4.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
CHAPTER 10. MIDDLE EAST & AFRICA CANCER THERAPEUTICS MARKET BY COUNTRY
10.1. Middle East & Africa Cancer Therapeutics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Middle East & Africa Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. GCC
10.3.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
10.4. South Africa
10.4.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
10.5. Rest of Middle East & Africa
10.5.1. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Treatment Type, 2015 – 2026 ($Million)
CHAPTER 11. COMPANY PROFILE
11.1. AbbVie Inc.
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Astellas Pharma Inc.
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Bristol Myers Squibb Company
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Celgene Corporation
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Eli Lilly and Company
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. F. Hoffmann-La Roche Ltd.
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Johnson & Johnson
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Merck & Co., Inc.
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Novartis AG
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. Pfizer Inc.
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Others
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies
CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/1626
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
